Mineralocorticoid receptors: an appealing target to treat coronary microvascular dysfunction in diabetes

Diabetes. 2015 Jan;64(1):3-5. doi: 10.2337/db14-1425.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Coronary Circulation / drug effects*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Angiopathies / drug therapy*
  • Female
  • Humans
  • Male
  • Microcirculation / drug effects*
  • Mineralocorticoid Receptor Antagonists / administration & dosage*
  • Spironolactone / administration & dosage*

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone